Immutep Limited announced that Non-Executive Director Grant Chamberlain passed away suddenly and unexpectedly on 28 January 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.435 AUD | +3.57% |
|
+10.13% | +26.09% |
06-25 | Immutep Gets Exclusive Rights to Develop, Commercialize New Anti-LAG-3 Small Molecules | MT |
06-25 | Immutep Signs Agreement with Cardiff University for Development Cancer Treatment | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.09% | 397M | |
+30.06% | 52.73B | |
+37.49% | 39B | |
-9.20% | 38.52B | |
+28.47% | 30.38B | |
-12.26% | 26.39B | |
+11.47% | 26.08B | |
+45.69% | 14.15B | |
+33.22% | 12.6B | |
-5.50% | 11.51B |
- Stock Market
- Equities
- IMM Stock
- News Immutep Limited
- Immutep Limited Announces Demise of Grant Chamberlain, Non-Executive Director